Protective action figurations for superoxide dismutase - chondroitin sulfate - catalase bienzyme conjugate after its medicative administration in endotoxin shock
Previously it found that the bienzymatic conjugate superoxide dismutase-chondroitin sulfate, catalase (SOD-CHS-CAT) increased the survival rate of rats with endotoxic shock caused by the administration of lipopolysaccharide (LPS). This effect was observed both in preventive (before LPS) and therapeutic conjugate administration (after the administration of LPS). This study shows that the development of endotoxic shock is accompanied by increased levels of NO in the liver, lungs, kidneys, heart; administration of the SOD-CHS-CAT conjugate insignificantly influenced this parameter. At the same time, the changes in blood urea and creatinine suggest the protective effect of the conjugate on renal function, while diverse changes in biochemical parameters studied complicate the formation of the agreed conclusions on the state of other organs.
Maksimenko A.V., Vavaeva A.V., Zvyagintseva M.A., Abramov A.A., Timoshin A.A., Vavaev A.V., Lakomkin V.L. (2016) Protective action figurations for superoxide dismutase - chondroitin sulfate - catalase bienzyme conjugate after its medicative administration in endotoxin shock. Biomeditsinskaya Khimiya, 62(3), 295-301.
Maksimenko A.V. et al. Protective action figurations for superoxide dismutase - chondroitin sulfate - catalase bienzyme conjugate after its medicative administration in endotoxin shock // Biomeditsinskaya Khimiya. - 2016. - V. 62. -N 3. - P. 295-301.
Maksimenko A.V. et al., "Protective action figurations for superoxide dismutase - chondroitin sulfate - catalase bienzyme conjugate after its medicative administration in endotoxin shock." Biomeditsinskaya Khimiya 62.3 (2016): 295-301.
Maksimenko, A. V., Vavaeva, A. V., Zvyagintseva, M. A., Abramov, A. A., Timoshin, A. A., Vavaev, A. V., Lakomkin, V. L. (2016). Protective action figurations for superoxide dismutase - chondroitin sulfate - catalase bienzyme conjugate after its medicative administration in endotoxin shock. Biomeditsinskaya Khimiya, 62(3), 295-301.
References
Maksimenko A.V., Tishhenko E.G. (1997) Biokhimiya, 62(10), 1364-1368. Scholar google search
Tunctan B., Sari A.N., Kacan M., Unsal D., Buharalioglu C.K., Sahan-Firat S., Korkmaz B., Falck J.R., Malik K.U. (2013) Prostaglandins Other Lipid Mediat., 93-108. Scholar google search
Thiemermann C., Ruetten H., Wu C.-C., Vane J.R. (1995) British J. Phamacol., 116, 2845-2851. Scholar google search
Cuzzocrea S., Mazzon E., Di Paola R., Esposito E., Macarthur H., Matuschak G.M., Salvemini D. (2006) J. Pharm. Experim. Ther., 319, 73-81. Scholar google search
Sharp P.E., La Regina M.C. (1998) in: Laboratory Rats (Editor-in-Chief Mark A. Suckow) CRC Press, Boca Ramos, Boston, London, New York, Washington, D.C. Scholar google search
Crespo E., Maci’as M., Pozo D., Escames G., Martin M., Vives F., Guerrero J.M., A-Castroviejo D.A. (1999) FASEB J., 13, 1537-1546. Scholar google search
Ruetten H., Southan G.J., Abate A., Thiemermann C. (1996) British J. Pharmacol., 118, 261-270. Scholar google search
Shi D.-W., Zhang J., Jiang H.-N., Tong C.-Y., Gu G.-R., Ji Y., Summah H., Qu J.-M. (2011) Inflamm. Res., 60, 841-849. Scholar google search
Lowes D.A., Webster N.R., Murphy M.P., Galley H.F. (2013) British J. Anaesthesia, 110(3), 472–480. CrossRef Scholar google search
